-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Revolution Medicines, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q3 2024.
- Revolution Medicines, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$176M, a 42.6% decline year-over-year.
- Revolution Medicines, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$653M, a 77.1% decline year-over-year.
- Revolution Medicines, Inc. annual Operating Income (Loss) for 2023 was -$487M, a 88.6% decline from 2022.
- Revolution Medicines, Inc. annual Operating Income (Loss) for 2022 was -$258M, a 37.4% decline from 2021.
- Revolution Medicines, Inc. annual Operating Income (Loss) for 2021 was -$188M, a 69.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)